Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Global trends and inequalities in breast cancer survival and care

Prof Claudia Allemani, Dr Ophira Ginsburg, Prof Vesna Zadnik
Global trends and inequalities in breast cancer survival and care ( Prof Claudia Allemani, Dr Ophira Ginsburg, Prof Vesna Zadnik )
22 Feb 2024

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )
22 Feb 2024

Adding daratumumab to VRd shows better efficacy outcomes compared to VRd alone in multiple myeloma

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands
Adding daratumumab to VRd shows better efficacy outcomes compared to VRd alone in multiple myeloma ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
14 Feb 2024

Global Coalition for Radiotherapy - How to integrate radiotherapy in cancer control plans

Prof Richard Sullivan, Dr Lisa Stevens and Prof Pat Price
Global Coalition for Radiotherapy - How to integrate radiotherapy in cancer control plans ( Prof Richard Sullivan, Dr Lisa Stevens and Prof Pat Price )
12 Feb 2024

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results

Dr Lorraine Chantrill - University of Sydney, Sydney, Australia
Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results ( Dr Lorraine Chantrill - University of Sydney, Sydney, Australia )
9 Feb 2024

Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC

Prof Hironaga Satake - Kochi Medical School, Kochi, Japan
Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC ( Prof Hironaga Satake - Kochi Medical School, Kochi, Japan )
8 Feb 2024

Pembrolizumab a promising option for MIUC patients after radical surgery

Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pembrolizumab a promising option for MIUC patients after radical surgery ( Dr Andrea  Apolo - National Cancer Institute, Bethesda, USA )
5 Feb 2024

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi Kitamura
ASCO GU 2024: Latest in PARP inhibitors for prostate cancer ( Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi Kitamura )
31 Jan 2024

Updates on lung cancer from WCLC and ESMO 2023

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
Updates on lung cancer from WCLC and ESMO 2023 ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
31 Jan 2024

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Dr Bruce Montgomery - University of Washington, Seattle, USA
Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems ( Dr Bruce Montgomery - University of Washington, Seattle, USA )
31 Jan 2024

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis

Dr Scott Eggener - The University of Chicago, Chicago, USA
Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis ( Dr Scott Eggener - The University of Chicago, Chicago, USA )
31 Jan 2024

Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC

Dr Saby George - Roswell Park Comprehensive Cancer Center, New York, USA
Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC ( Dr Saby George - Roswell Park Comprehensive Cancer Center, New York, USA )
30 Jan 2024